Position in AZN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$123,948,035
New position
Shares Held
628,476
first reported quarter
Ownership
0.041%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 21.600983967565984.ToString("F0")%
Shared 0.ToString("F0")%
None 78.399016032434.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Man Group plc holds $1,645,149,077 across 10 Drug Manufacturers - General names. AZN ranks #4 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
422,016 | $388,157,656 | |
| 2 | ABBV |
AbbVie Inc.
|
1,774,415 | $385,917,516 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
5,658,497 | $343,187,842 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
628,476 | $123,948,035 | |
| 5 | MRK |
Merck & Co., Inc.
|
793,167 | $95,410,057 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
678,066 | $94,502,057 | |
| 7 | JNJ |
Johnson & Johnson
|
318,085 | $77,752,697 | |
| 8 | BIIB |
Biogen Inc.
|
318,745 | $58,435,520 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $123,948,035 | 628,476 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||